AF
Ami Fadia Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
139
Avg Return
Past Year
Past Year
6.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
86.4%
Neutral
13.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $250 |
32%
upside
| 1 | +35% |
0
%
| 16 Oct ‘25 3 days ago |
|
|
|
Buy
Initiated
| $19 |
41%
upside
| 1 | +7.1% |
0
%
| 13 Oct ‘25 6 days ago |
|
|
|
Buy
Initiated
| $12 |
86%
upside
| 1 | +26% |
0
%
| 13 Oct ‘25 6 days ago |
|
|
|
Buy
Initiated
| $28 |
105%
upside
| 1 | +16% |
0
%
| 13 Oct ‘25 6 days ago |
|
|
|
Buy
Reiterated
| $11 |
97%
upside
| 3 | +24% |
0
%
| 30 Sep ‘25 19 days ago |
|
|
|
Hold
Downgraded
| $96 |
1%
upside
| 2 | +5.2% |
0
%
| 29 Sep ‘25 20 days ago |
|
|
|
Buy
Maintained
| $28 |
34%
upside
| 1 | +7.3% |
0
%
| 24 Sep ‘25 25 days ago |
|
|
|
Buy
Maintained
| $41 |
58%
upside
| 1 | -1.9% |
0
%
| 24 Sep ‘25 25 days ago |
|
|
|
Hold
Reiterated
| – | – | 2 | -6.5% |
0
%
| 24 Sep ‘25 25 days ago |
|
|
|
Buy
Maintained
| $170 |
21%
upside
| 1 | +15% |
0
%
| 22 Sep ‘25 27 days ago |
|
|
|
Buy
Maintained
| $66 |
22%
upside
| 2 | +2.3% |
0
%
| 11 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $202 |
48%
upside
| 2 | +2.2% |
0
%
| 28 Aug ‘25 1 month ago |
|
|
|
Buy
Maintained
| $16 |
122%
upside
| 1 | -11% |
0
%
| 6 Aug ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $150 |
17%
upside
| 1 | +3.8% |
0
%
| 4 Aug ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $45 |
49%
upside
| 2 | +0.98% |
0
%
| 29 Jul ‘25 2 months ago |
|